Relay Therapeutics Inc.

NASDAQ: RLAY · Real-Time Price · USD
3.54
0.15 (4.42%)
At close: Aug 15, 2025, 3:59 PM
3.60
1.80%
After-hours: Aug 15, 2025, 07:53 PM EDT

Relay Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-70.38M -77.06M -76M -88.11M -92.21M -81.39M -83.5M -65.73M -98.5M -94.24M -67.5M -84.17M -76.79M -62.05M -67.46M -60.83M -193.4M -42.18M
Depreciation & Amortization
-392K -389K 1.33M -8.77M 1.37M 1.4M 1.38M 1.36M 1.33M 1.2M 1.17M 1.03M 956K 975K 1.03M 1.01M 960K 919K
Stock-Based Compensation
14.5M 19.32M 17.64M 22.48M 26.83M 27.19M 19.27M 21.84M 23.41M 21.52M 13.82M 13.72M 15.15M 13.46M 10.22M 12.42M 16.15M 9.67M
Other Working Capital
-956K -11.63M -9.81M -16.52M 9.64M 333K -37.13M 359K 409K 5.99M 4.47M -5.01M -58K 3.45M 46K 45K 56K 130K
Other Non-Cash Items
2.92M n/a -2.28M 20.13M -14.66M -5.5M -10.81M -1.2M -2.15M -3.02M -10.93M 3.6M 200K -3.91M 836K 2M 135.4M 153K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a 5.08M -2.88M -2.2M n/a n/a n/a n/a n/a 681K 670K -1K n/a
Change in Working Capital
-1.91M -15.08M 1.45M -20.82M 12.84M 7.98M -20.6M -28.79M 9.51M 7.41M 6.37M -327K 2.85M 2.36M 14.98M -8.46M 12.75M 78.08M
Operating Cash Flow
-55.26M -73.21M -57.87M -75.08M -65.83M -50.32M -89.19M -75.4M -68.6M -67.13M -57.08M -66.14M -57.09M -49.17M -39.71M -53.2M -28.14M 46.64M
Capital Expenditures
-26K -384K n/a -227K -11K -1.78M -118K -590K -1.5M -1.92M -2.32M -2.1M -1.86M -2.79M -880K -1.74M -379K -476K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a -257.63M -71.95M -52.78M -77.23M 144.62M -29.28M n/a n/a -83K -83K -25.13M n/a
Purchase of Investments
-8.93M -21.97M -75.08M -265.13M -119.63M -190.78M -136.81M -84.75M -66.16M -97.81M -327.64M -55.83M -24.25M -127.69M -327.03M -7.39M -26.92M -619.32M
Sales Maturities Of Investments
84.1M 64.82M 104.07M 139.2M 165.19M 203.09M 196.61M 156.71M 118.94M 175.04M 183.02M 85.11M 69.5M 18.1M 35.25M 30M 78.5M 386.18M
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a 257.63M 71.95M 52.78M 77.23M -144.62M 29.28M 45.24M -109.59M -291.78M 22.61M -25.13M -233.15M
Investing Cash Flow
75.15M 42.47M 29M -126.16M 45.55M 10.53M 59.68M 71.36M 51.28M 75.31M -146.94M 27.19M 43.39M -112.38M -292.75M 20.79M 26.07M -233.62M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
653K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a 266.69M 732K n/a 1.19M 1M 95K 2.08M 1.3M 1.17M 285.87M 2M 883K 1.8M n/a n/a n/a
Financial Cash Flow
653K n/a 800K 218.89M 1.54M 48.92M 21.92M 9.46M 2.08M 1.3M 1.17M 285.87M 2M 883K 384.01M 902K 1.12M 2.06M
Net Cash Flow
20.54M -30.75M -28.07M 17.64M -18.74M 9.13M -7.59M 5.43M -15.24M 9.48M -202.85M 246.91M -11.71M -160.67M 51.56M -31.51M -951K -184.93M
Free Cash Flow
-55.29M -73.59M -57.87M -75.31M -65.84M -52.1M -89.31M -75.99M -70.1M -69.05M -59.4M -68.24M -58.95M -51.97M -40.59M -54.94M -28.52M 46.16M